https://fr.sputniknews.com/20211223/la-russie-autorise-un-nouveau-medicament-anti-covid-administre-par-inhalation-1054033876.html
Russia approves new anti-Covid drug administered by inhalation
Russia approves new anti-Covid drug administered by inhalation
A new drug for the treatment of Covid-19 administered by inhalation has been registered in Russia, according to its designer, the Federal Biomedical Agency … 23.12.2021, Sputnik France
2021-12-23T00:30+0100
2021-12-23T00:30+0100
2021-12-23T00:30+0100
medications
veronika skvortsova
/html/head/meta[@name=”og:title”]/@content
/html/head/meta[@name=”og:description”]/@content
–
https://cdnnfr1.img.sputniknews.com/img/07e5/0c/17/1054034276_0:658:2048:1810_1920x0_80_0_0_6b4e1e39e26af44172a86e409302bee6.jpg
MIR 19, this is the name of a new anti-Covid preparation authorized by the Russian Ministry of Health, announces this Wednesday, December 22 the Russian Federal Biomedical Agency (FMBA). Developed by specialists of the FMBA, the MIR 19 is administered by inhalation over 10-15 minutes and is composed of a substance containing small molecules of RNA interfering to block the multiplication of the coronavirus in the body.The drug has been shown to be effective in phase I clinical trials and II, in which patients with severe forms of Covid-19 took part.According to the director of the FMBA, the former Russian Minister of Health Veronika Skvortsova, interviewed by the Russian channel Rossiya 24, after the first inhalation of MIR 19 there is a “reduction in viral pressure” without “unpleasant side effects”. US anti-Covid pill This same Wednesday, December 22, in the United States, the United States Food and Drug Administration (FDA) has at torized Pfizer’s antiviral pill, Paxlovid, to treat Covid-19 in high-risk people 12 years of age and older, the first antiviral pill approved for home use for people with HIV infection. coronavirus and weighing more than 40 kg, before they were sick enough to be hospitalized. According to the designers of Paxlovid, if three pills are administered twice daily within a few days of the onset of symptoms, the risk of hospitalization or death decreases by 89%.
Sputnik France
+74956456601
MIA “Rosiya Segodnya”
2021
Kirill Batarin
https://cdnnfr1.img.sputniknews.com/img/07e5/04/02/1045430205_50:0:2070:2019_100x100_80_0_0_e1d7fbb08e90d4c0262bbfcb9e8a18a6.jpg
–
Kirill Batarin
https://cdnnfr1.img.sputniknews.com/img/07e5/04/02/1045430205_50:0:2070:2019_100x100_80_0_0_e1d7fbb08e90d4c0262bbfcb9e8a18a6.jpg
–
fr_FR
Sputnik France
+74956456601
MIA “Rosiya Segodnya”
–https://cdnnfr1.img.sputniknews.com/img/07e5/0c/17/1054034276_0:466:2048:2002_1920x0_80_0_0_7d89a862303c7d77e5657d4f9db10a3c.jpg
Sputnik France
+74956456601
MIA “Rosiya Segodnya”
Kirill Batarin
https://cdnnfr1.img.sputniknews.com/img/07e5/04/02/1045430205_50:0:2070:2019_100x100_80_0_0_e1d7fbb08e90d4c0262bbfcb9e8a18a6.jpg
–
russia, drugs, covid-19, us, veronika skvortsova
–
Kirill Batarin
A new drug for the treatment of Covid-19 administered by inhalation has been registered in Russia, according to its designer, the Russian Federal Biomedical Agency. A new medical tool that can be administered at home.
–
Developed by FMBA specialists, MIR 19 is administered by inhalation for 10-15 minutes and is composed of a substance containing small molecules of RNA interfering to block the multiplication of the coronavirus in the body.
–
The drug has proven its effectiveness in phase I and II clinical trials, in which patients with severe forms of Covid-19 participated.
–
According to the director of the FMBA, the former Russian Minister of Health Veronika Skvortsova, interviewed by the Russian channel Rossiya 24, after the first inhalation of MIR 19 there is a “reduction in viral pressure” without “unpleasant side effects”.
–
Pilule US anti-Covid
It is the first antiviral pill authorized to be taken at home for people infected with the coronavirus and weighing more than 40 kg, before they are sick enough to be hospitalized.
–
According to the developers of Paxlovid, if three pills are administered twice daily within a few days of the onset of symptoms, the risk of hospitalization or death is reduced by 89%.
— .
